BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Business

  Synergetics USA, Inc. Announces Record First Quarter Revenue for Fiscal 2008

  December 11, 2007

   · 

  1 min read
• Business

  Vice President and General Manager of Trauma Fixation and Senior Vice President of International Business Appointed by Smith & Nephew plc’s Orthopaedic Trauma & Clinical Therapies division

  December 11, 2007

   · 

  1 min read
• Rosetta Genomics Ltd. Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008

  December 11, 2007

   · 

  4 min read
• Drug Development

  CuraGen Corporation and TopoTarget A/S Report Belinostat Results Presented at American Society of Hematology and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

  December 11, 2007

   · 

  9 min read
• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Release: VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial

  December 11, 2007

   · 

  8 min read
• Drug Development

  Cell Therapeutics, Inc. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin’s Lymphoma

  December 11, 2007

   · 

  7 min read
• Drug Development

  Anavex Life Sciences Corp. Release: ANAVEX 7-1037 Demonstrates Chemotherapeutic Potential without Toxic Side Effects

  December 11, 2007

   · 

  6 min read
• Biotech Bay

  Human Pheromone Sciences Announces Stock Repurchase Program

  December 11, 2007

   · 

  1 min read
• Drug Development

  Chimerix, Inc. Initiates a Multi-dose Clinical Trial of the Company’s Lead Compound, CMX001, for the Treatment for Smallpox Infection

  December 11, 2007

   · 

  1 min read
• BioForest

  Oncolytics Biotech Inc. Announces Issuance of 25th U.S. Patent

  December 11, 2007

   · 

  2 min read